Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

A novel protein therapy for efficient skin wound healing

A group of researchers at A*STAR’s (Agency for...

Mandatory headwear does not influence surgical site infections

Surgical site infections are noteworthy and...

Nuevo objetivo “universal” para el tratamiento antiviral

Con nuevos virus que representan una amenaza...

Por qué la resistencia a los antibióticos es más preocupante que nunca

Susan Brink, una escritora independiente para...

Audio Interview: Building a Successful Public Health Response to Covid-19

The continuing spread of SARS-CoV-2 remains a...

¿Qué es la osteomielitis?

El Dr. Pablo S. Corona (Unidad de Patología...

Infección articular periprotésica

Infecciones_Periprotesicas_Imp...

Distribuidor exclusivo.

0